Impaired Generation of 12-Hydroxylated Bile Acids Links Hepatic Insulin Signaling with Dyslipidemia

Autor: Carrie L. Welch, Matthew Pratt-Hyatt, Curtis D. Klaassen, Rebecca A. Haeusler, Domenico Accili
Rok vydání: 2012
Předmět:
Male
medicine.medical_specialty
Very low-density lipoprotein
medicine.drug_class
Physiology
medicine.medical_treatment
Receptors
Cytoplasmic and Nuclear

030209 endocrinology & metabolism
Type 2 diabetes
Biology
Hydroxylation
Article
Bile Acids and Salts
03 medical and health sciences
Mice
0302 clinical medicine
Internal medicine
medicine
Animals
Insulin
Steroid 12-alpha-Hydroxylase
Molecular Biology
Triglycerides
030304 developmental biology
Dyslipidemias
Mice
Knockout

0303 health sciences
Bile acid
Forkhead Box Protein O1
Lipid metabolism
Forkhead Transcription Factors
Isoxazoles
Cell Biology
medicine.disease
Lipid Metabolism
3. Good health
Insulin receptor
Endocrinology
Glucose
Diabetes Mellitus
Type 2

Liver
biology.protein
Metabolome
lipids (amino acids
peptides
and proteins)

Metabolic syndrome
CYP8B1
Signal Transduction
Zdroj: Cell Metabolism. 15(1):65-74
ISSN: 1550-4131
DOI: 10.1016/j.cmet.2011.11.010
Popis: SummaryThe association of type 2 diabetes with elevated plasma triglyceride (TG) and very low-density lipoproteins (VLDL), and intrahepatic lipid accumulation represents a pathophysiological enigma and an unmet therapeutic challenge. Here, we uncover a link between insulin action through FoxO1, bile acid (BA) composition, and altered lipid homeostasis that brings new insight to this longstanding conundrum. FoxO1 ablation brings about two signature lipid abnormalities of diabetes and the metabolic syndrome, elevated liver and plasma TG. These changes are associated with deficiency of 12α-hydroxylated BAs and their synthetic enzyme, Cyp8b1, that hinders the TG-lowering effects of the BA receptor, Fxr. Accordingly, pharmacological activation of Fxr with GW4064 overcomes the BA imbalance, restoring hepatic and plasma TG levels of FoxO1-deficient mice to normal levels. We propose that generation of 12α-hydroxylated products of BA metabolism represents a signaling mechanism linking hepatic lipid abnormalities with type 2 diabetes, and a treatment target for this condition.
Databáze: OpenAIRE